At a glance
- Originator Kotobuki Seiyaku
- Class Anti-ischaemics; Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies; Small molecules; Thiazepines
- Mechanism of Action Calcium channel antagonists; Potassium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Hypertension; Ischaemic heart disorders
Most Recent Events
- 01 Aug 1997 Suspended-I for Hypertension in USA (Unknown route)
- 25 Mar 1997 Discontinued-II for Hypertension in Japan (Unknown route)
- 25 Mar 1997 Discontinued-II for Ischaemic heart disorders in Japan (Unknown route)